| DRUG WATCH |
|
| Year : 2013 | Volume
: 45
| Issue : 5 | Page : 530-531 |
Ceftriaxone-induced hemolysis
Vivek S Guleria, Nitin Sharma, Sagar Amitabh, Velu Nair
Department of Internal Medicine, Armed Forces Medical College, Pune - 411 040, India
Correspondence Address:
Vivek S Guleria
Department of Internal Medicine, Armed Forces Medical College, Pune - 411 040
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.117758
Immune hemolytic anemia is a rare adverse effect of ceftriaxone, a third-generation cephalosporin, which is a commonly used antibiotic. We describe a 60-years-old lady, a case of community-acquired pneumonia, who developed severe hemolysis after the first dose of ceftriaxone. Her hemoglobin dropped from 9.6 g /dl to 5.5 g /dl. However, she improved after discontinuation of the drug and blood transfusion. This report serves as a reminder to medical fraternity that life-threatening hemolysis can rarely follow administration of ceftriaxone.
[FULL TEXT] [PDF]*
|
